This trial is evaluating whether Facilitated group therapy with behavioral practice; 16 weeks will improve 1 primary outcome and 1 secondary outcome in patients with Hoarding Disorder. Measurement will happen over the course of Change from baseline at 8 weeks and 16 weeks after treatment.
This trial requires 20 total participants across 2 different treatment groups
This trial involves 2 different treatments. Facilitated Group Therapy With Behavioral Practice; 16 Weeks is the primary treatment being studied. Participants will all receive the same treatment. There is no placebo group. The treatments being tested are not being studied for commercial purposes.
The most common treatment for hoarding disorder was CBT, while antidepressants, naltrexone, and/or a combination of these were the most commonly used medications for treatment of the obsessive-compulsive symptoms, and medications are used in combination to treat other comorbidities such as substance abuse.
Results from a recent paper suggest that hoarding can be primarily attributed or at least associated with various forms of personality disorders and mood disorders. More studies may determine the precise contribution of these disorders to hoarding. Furthermore, research and clinical implications of psychiatric comorbidity of hoarding, such as interpersonal issues, needs to be explored.
There is no evidence that any form of treatment can stop or cause the relapse of hoarding disorders; therefore there is no evidence that hoarding disorder can be cured.
Currently, there is a lack of national statistics of persons who are diagnosed with Hoarding Disorder. Because of this, it is difficult to determine how many patients have this disorder. The national prevalence estimate of Hoarding Disorder in the United States is 1.5 cases for every 100,000 persons. However, with a recent article reporting an average of 7.5 cases per 100,000 persons, we may hypothesize that the national prevalence of the disorder could have been even higher. The high incidence or prevalence estimates of this psychiatric disorder are important to inform public health professionals about the necessity of developing national data of Hoarding disorder.
Signs of HD include compulsive hoarding of items to a degree that makes life difficult or impossible. Some individuals may also have trouble keeping track of their possessions. The disorder also impairs one's life functioning. Children who have a parent who has hoarding disorder should have their hoarding status investigated and be watched closely for symptoms or signs of HD. Children with HD also can have severe emotional problems, such as low self esteem and low self esteem because of the hoarding and other symptoms mentioned earlier. Children with HD should be brought on a schedule of visits to the doctor for an evaluation and follow up as needed.
If untreated, HD may be fatal over 3 to 4 years. If treated, outcomes are generally very good. Treatment is recommended for all HD patients.
Facilitated group interventions for adults with hoarding disorder are safe and effective for the duration of the group. Further research should aim to replicate the positive results on long-term outcome.
The group model of therapy for hoarding disorder in psychiatric patients is effective in improving symptoms associated with the disorder. Further trials are needed to evaluate its effectiveness as an adjunct to individual therapy.
Our preliminary findings suggest that, at least to some extent, hoarding disorder is genetically transmitted. However, the effect of the heritable liability on familial transmission is likely small (if any) and is not readily apparent from the present sample sizes. Future studies should focus on the identification of specific genes, if any, that influence hoarding disorder phenotype, including psychiatric and neurological comorbidities.
Findings suggest that this type of group facilitator-administered intervention for patients with hoarding disorder produced improvements in quality of life. These beneficial effects were maintained 6 months post-intervention.
There is a broad variation in the average age individuals develop HoD. Since this condition is associated with significant social and economical costs, it is important for psychiatrists and other health care providers in managing HoD to be aware of this variation.